Nicholas H. Oberlies
NIH Rank #7690
- Program Leader
- Multi-Institutional
- Early Career
- Diverse Portfolio
NIH Funding · FY2024
Total Funding
$1.6M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#7,690
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $1.6M across 3 grants · National rank #7690.
Top grants by award amount
Nicholas H. Oberlies's NIH grant portfolio, ranked by award amount.
- 5R44CA285062-02R44Assigning mode of action to phenotypically discovered anticancer leads.$1Maward amount
- 5U54AT008909-10U54Natural Product-Drug Interaction Research: The Roadmap to Best Practices$470.7Kaward amount
- $143.3Kaward amount
Affiliations
Institutions that have administered grants for Nicholas H. Oberlies.
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardAttagene, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #7690
- 2024Multi-Institutional ResearchAwards at 3 institutions
Related investigators
Other NIH-funded PIs frequently associated with Nicholas H. Oberlies.
Explore further
Find collaborators for Nicholas H. Oberlies
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Attagene, Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →